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Background:  Myxoma is the most common heart’s primary tumor and has an annual incidence of 0.5/million patients. The clinical 
manifestations are variable and depend on size, mobility and location of the tumor. Most patients have at least one of the signs of the 
classic triad of symptoms: heart obstruction, signs of systemic embolisation and constitutional symptoms. 
methods:  The records of 74 patients with an initial diagnosis of cardiac myxoma made by echocardiography and subsequently confirmed 
by pathology during the period from 1982 to 2013 were revised. The static analysis was done using Fisher and Mann-Whitney’s exact test. 
results:  The patients’ ages ranged from 10 to 79 years (average 50.82, ± 14.3) and the average follow-up time was 4.7 years. 62.2% of 
the patients were female and 86.8% of the tumors were located in the left atrium. The most frequent symptom was obstructive dyspnea 
(59.7%), tumoral embolism was present in 16.3% of the cases and the most common systemic manifestation was fatigue in 12.2%. 
98.6% of patients underwent surgical resection of the myxoma and the most frequent post-operative complication was atrial fibrillation 
(AF), present in 18.6%. There were no deaths in the immediate post-operative period and there were two late deaths. Only one patient 
had tumor recurrence. There was no evident significant correlation of location or tumor size with stroke (p 0, 52 and 0.33, respectively). 
Also, there was not significance between tumor size with the occurrence of AF (p0, 72). There was a significant association between the 
presence of symptoms of right-sided heart failureand tumor size (p 0.021).
conclusion:  Atrial fibrillation was the most common complication in the evolution and signs of systemic embolic were the most serious 
and occurred in 16.3% of the cases, which justifies the consideration for anticoagulation. Rates of tumor recurrence and its complications 
are low
